NICE Guidance Expected To Add 1.4 Million To Roster Of Statin Users
An additional 1.4 million patients in England and Wales are expected to begin using statins as a result of guidance directing doctors to identify patients at high-risk for cardiovascular disease
You may also be interested in...
Revised cholesterol treatment guidelines could result in increased use of combination lipid-lowering therapies as Merck/Schering-Plough's Vytorin enters the market
Industry also seems supportive of the idea, while Pew touts the power of the power of track-and-trace as a deterrent.
EMD Serono has been tracking Serostim packages since 2002; J&J is using Prezista 600 mg as a trial run for serialization.